EUCTR2006-005320-16-DE进行中（未招募）不适用
ong-term Observational Follow-up Study of a Multicenter, Randomized, Double-blind, Placebo-controlled, Comparative Trial of AMD3100 (240 µg/kg) plus G-CSF (10 µg/kg) Versus G-CSF (10 µg/kg) plus Placebo to Mobilize and Collect = 6×106 CD34+ Cells/kg in Multiple Myeloma Patients for Autologous Transplantation
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 入组人数
- 10
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •All patients who received at least 1 dose of study treatment (placebo or plerixafor) in protocol AMD3100-3102.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- 未提供
研究者
相似试验
已完成
Unknown
An observational study after completion of a multicenter open-label uncontrolled trial in pleurodesis for secondary intractable pneumothorax with sterile graded talcPatients who participated in an investigator-initiated phase II study in pleurodesis for secondary intractable pneumothorax with sterile graded talc (protocol number: J-TALC2) with absence of chest tube removal within 30 days after pleurodesis, and who still have been hospitalized.JPRN-jRCT1091220271ational Hospital Organization Nagoya Medical Center Hideo Saka30
进行中（未招募）
1 期
A study to investigate the long-term safety and efficacy of a new drug, NI-0501, in children with a disease that is called Haemophagocytic LymphohistiocytosisHaemophagocytic lymphohistiocytosisMedDRA version: 18.0Level: SOCClassification code 10010331Term: Congenital, familial and genetic disordersSystem Organ Class: 10010331 - Congenital, familial and genetic disordersEUCTR2012-005753-23-ATovImmune SA10
进行中（未招募）
1 期
A study to investigate the long-term safety and efficacy of a new drug, NI-0501, in children with a disease that is called Haemophagocytic Lymphohistiocytosis.Haemophagocytic lymphohistiocytosisMedDRA version: 20.0Level: LLTClassification code 10071583Term: Haemophagocytic lymphohistiocytosisSystem Organ Class: 100000004851EUCTR2012-005753-23-FRovimmune SA55
进行中（未招募）
不适用
A study to investigate the long-term safety and efficacy of a new drug, NI-0501, in children with a disease that is called reactivated Primary Haemophagocytic Lymphohistiocytosis.EUCTR2012-005753-23-CZovImmune SA10
进行中（未招募）
1 期
A study to investigate the long-term safety and efficacy of a new drug, NI-0501, in children with a disease that is called reactivated Primary Haemophagocytic Lymphohistiocytosis.Primary haemophagocytic lymphohistiocytosis which has reactivated.MedDRA version: 14.1Level: SOCClassification code 10010331Term: Congenital, familial and genetic disordersSystem Organ Class: 10010331 - Congenital, familial and genetic disordersEUCTR2012-005753-23-ESovImmune SA58